JOGO Health Revolutionizes Chronic Pain Treatment with $5.5M Funding Round
June 20, 2024, 3:44 am
JOGO Health, a groundbreaking medtech company based in New York City, has recently closed a significant funding round of $5.5 million. This investment, led by Hourglass Ventures, marks a pivotal moment for JOGO Health as it continues to revolutionize the treatment of chronic pain and neuromuscular disorders using its AI-powered patented technology.
By harnessing the brain's natural neuroplasticity, JOGO Health's innovative wearable technology and app offer a transformative approach to providing non-invasive, drug-free relief for a range of conditions, including chronic lower back pain, stroke recovery, migraines, and incontinence. With the stamp of approval from the FDA and reimbursement by Medicare and commercial insurance, JOGO Health is making waves in the healthcare industry by expanding a $380 billion market without the reliance on traditional pharmaceuticals or surgical interventions.
Having already treated over 25,000 patients and completed more than 100,000 sessions across a network of 50+ hospital partners, including prestigious institutions like Mayo Clinic and Mount Sinai Hospital, JOGO Health is making a tangible impact on the lives of individuals suffering from chronic pain and neuromuscular disorders.
The driving force behind JOGO Health's success is its dedicated team of accomplished healthcare entrepreneurs, who bring a wealth of experience from renowned institutions such as Columbia University, Harvard University, Yale University, AT&T, Johnson & Johnson, and Astrazeneca. Co-Founder and CEO Sanjai Murali, a visionary leader, has steered JOGO Health from its inception to FDA market authorization, while President and Co-Founder Siva Nadarajah has a proven track record of success in the healthcare industry, having previously sold an AI healthcare startup to leading clinical research company IQVIA.
The recent funding round, which saw participation from both institutional investors like Mayo Clinic Ventures and retail investors through a Regulation CF community investment round on Wefunder, underscores the growing demand and confidence in JOGO Health's mission to democratize healthcare. By opening up investment opportunities to the public, JOGO Health is paving the way for a future where healthcare is accessible to all, not just a privileged few.
With the capital raised from this funding round, JOGO Health is poised to accelerate its commercial launch and solidify its position as the go-to solution for chronic pain and neuromuscular disorders, impacting the lives of millions globally. The community investment round on Wefunder, with a minimum investment of $100, offers individuals the chance to be a part of this transformative journey towards better healthcare for all.
Join the revolution and invest in JOGO Health's vision of 'by the world, for the world' today. Visit wefunder.com/jogohealth for more information on how you can be a part of this groundbreaking movement in healthcare.
Source: Business Wire
Sanjai Murali, CEO and Co-Founder
sanjai.murali@jogohealth.com
VentureBeat Daily
Stay informed with the latest news delivered to your inbox daily. Subscribe now to VentureBeat's Terms of Service. Thank you for subscribing. Explore more VentureBeat newsletters here. An error occurred.
By harnessing the brain's natural neuroplasticity, JOGO Health's innovative wearable technology and app offer a transformative approach to providing non-invasive, drug-free relief for a range of conditions, including chronic lower back pain, stroke recovery, migraines, and incontinence. With the stamp of approval from the FDA and reimbursement by Medicare and commercial insurance, JOGO Health is making waves in the healthcare industry by expanding a $380 billion market without the reliance on traditional pharmaceuticals or surgical interventions.
Having already treated over 25,000 patients and completed more than 100,000 sessions across a network of 50+ hospital partners, including prestigious institutions like Mayo Clinic and Mount Sinai Hospital, JOGO Health is making a tangible impact on the lives of individuals suffering from chronic pain and neuromuscular disorders.
The driving force behind JOGO Health's success is its dedicated team of accomplished healthcare entrepreneurs, who bring a wealth of experience from renowned institutions such as Columbia University, Harvard University, Yale University, AT&T, Johnson & Johnson, and Astrazeneca. Co-Founder and CEO Sanjai Murali, a visionary leader, has steered JOGO Health from its inception to FDA market authorization, while President and Co-Founder Siva Nadarajah has a proven track record of success in the healthcare industry, having previously sold an AI healthcare startup to leading clinical research company IQVIA.
The recent funding round, which saw participation from both institutional investors like Mayo Clinic Ventures and retail investors through a Regulation CF community investment round on Wefunder, underscores the growing demand and confidence in JOGO Health's mission to democratize healthcare. By opening up investment opportunities to the public, JOGO Health is paving the way for a future where healthcare is accessible to all, not just a privileged few.
With the capital raised from this funding round, JOGO Health is poised to accelerate its commercial launch and solidify its position as the go-to solution for chronic pain and neuromuscular disorders, impacting the lives of millions globally. The community investment round on Wefunder, with a minimum investment of $100, offers individuals the chance to be a part of this transformative journey towards better healthcare for all.
Join the revolution and invest in JOGO Health's vision of 'by the world, for the world' today. Visit wefunder.com/jogohealth for more information on how you can be a part of this groundbreaking movement in healthcare.
Source: Business Wire
Sanjai Murali, CEO and Co-Founder
sanjai.murali@jogohealth.com
VentureBeat Daily
Stay informed with the latest news delivered to your inbox daily. Subscribe now to VentureBeat's Terms of Service. Thank you for subscribing. Explore more VentureBeat newsletters here. An error occurred.